Inhibiting metastasis of breast cancer cells in vitro using gold nanorod-siRNA delivery system.

Breast cancer is the most common malignant disease in women, and it is not the primary tumor but its metastasis kills most patients with breast cancer. Anti-metastasis therapy based on RNA interference (RNAi) is emerging as one of promising strategies in tumor therapy. However, construction of an efficient delivery system for siRNA is still one of the major challenges. In this work, siRNA against protease-activated receptor-1 (PAR-1) which is a pivotal gene involved in tumor metastasis was conjugated to gold nanorods (AuNRs) via electrostatic interaction and delivered to highly metastatic human breast cancer cells. It was demonstrated that the siRNA oligos were successfully delivered into the cancer cells and mainly located in vesicle-like structures including lysosome. After transfected with the complex of AuNRs and PAR-1 siRNA (AuNRs@PAR-1 siRNA), expression of PAR-1 at both mRNA and protein levels were efficiently down regulated, as evidenced by quantitative real time PCR and flow cytometry analysis, respectively. Transwell migration assay confirmed the decrease in metastatic ability of the cancer cells. The silencing efficiency of the complex was in-between that of TurboFect and Lipofectamine, however, the cytotoxicity of the AuNRs was lower than that of the latter two. Taken together, AuNRs with PAR-1 siRNA are suited for RNAi based anti-metastasis therapy.

[1]  Jin-Zhi Du,et al.  Gold nanoparticles capped with polyethyleneimine for enhanced siRNA delivery. , 2010, Small.

[2]  Alaaldin M. Alkilany,et al.  Cation exchange on the surface of gold nanorods with a polymerizable surfactant: polymerization, stability, and toxicity evaluation. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[3]  W. Hennink,et al.  Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan. , 2010, Bioconjugate chemistry.

[4]  K. Hamad-Schifferli,et al.  Selective release of multiple DNA oligonucleotides from gold nanorods. , 2009, ACS nano.

[5]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[6]  Weiya Zhou,et al.  Well-controlled synthesis of Au@Pt nanostructures by gold-nanorod-seeded growth. , 2008, Chemistry.

[7]  Z. Salah,et al.  Protease-Activated Receptor-1 (hPar1), A Survival Factor Eliciting Tumor Progression , 2007, Molecular Cancer Research.

[8]  Xiaohua Huang,et al.  Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications , 2009, Advanced materials.

[9]  Adela C. Bonoiu,et al.  Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons , 2009, Proceedings of the National Academy of Sciences.

[10]  A. Sood,et al.  Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA. , 2008, Cancer research.

[11]  Arezou A Ghazani,et al.  Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.

[12]  Leaf Huang,et al.  An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Adela C. Bonoiu,et al.  Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication , 2010, Proceedings of the National Academy of Sciences.

[14]  Y. Liu,et al.  Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. , 2011, Nano letters.

[15]  Mark E. Davis,et al.  Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles , 2010, Nature.

[16]  Timothy J Shaw,et al.  Cellular uptake and cytotoxicity of gold nanorods: molecular origin of cytotoxicity and surface effects. , 2009, Small.

[17]  Sabine Neuss,et al.  Size-dependent cytotoxicity of gold nanoparticles. , 2007, Small.

[18]  K. Leong,et al.  Multifunctional nanorods for gene delivery , 2003, Nature materials.

[19]  M. Morilla,et al.  Ethylendiamine core PAMAM dendrimers/siRNA complexes as in vitro silencing agents. , 2009, International journal of pharmaceutics.

[20]  E. Winer,et al.  International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? , 2010, Journal of the National Cancer Institute.

[21]  Yi-Cheng Chen,et al.  DNA-gold nanorod conjugates for remote control of localized gene expression by near infrared irradiation. , 2006, Journal of the American Chemical Society.

[22]  Chad A Mirkin,et al.  Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles. , 2010, Bioconjugate chemistry.

[23]  K. Luk,et al.  An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes. , 2005, Biomaterials.

[24]  Hironobu Takahashi,et al.  Controlled release of plasmid DNA from gold nanorods induced by pulsed near-infrared light. , 2005, Chemical communications.

[25]  I. Verma,et al.  Gene therapy - promises, problems and prospects , 1997, Nature.

[26]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[27]  C. Shao,et al.  Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1 , 2009, Leukemia.

[28]  A. Agarwal,et al.  PAR1 Is a Matrix Metalloprotease-1 Receptor that Promotes Invasion and Tumorigenesis of Breast Cancer Cells , 2005, Cell.

[29]  M. Mareel,et al.  Commutators of PAR-1 signaling in cancer cell invasion reveal an essential role of the Rho–Rho kinase axis and tumor microenvironment , 2005, Oncogene.

[30]  Sutapa Barua,et al.  Simultaneous enhancement of photothermal stability and gene delivery efficacy of gold nanorods using polyelectrolytes. , 2009, ACS nano.

[31]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[32]  A. Chaudhuri,et al.  Cationic transfection lipids in gene therapy: successes, set-backs, challenges and promises. , 2003, Current medicinal chemistry.

[33]  Srirang Manohar,et al.  In vitro toxicity studies of polymer-coated gold nanorods , 2010, Nanotechnology.

[34]  R. Graham,et al.  Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells. , 2006, Cancer research.

[35]  Hong Ding,et al.  Gold Nanorods Coated with Multilayer Polyelectrolyte as Contrast Agents for Multimodal Imaging , 2007 .

[36]  Ying Liu,et al.  Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. , 2010, Biomaterials.

[37]  Feng Liu,et al.  Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. , 2005, Advanced drug delivery reviews.

[38]  M. El-Sayed,et al.  Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. , 2010, Journal of the American Chemical Society.

[39]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.